Special Issue "Novel Therapeutic Strategies for the Treatment of Brain Tumors"
Deadline for manuscript submissions: 15 February 2023 | Viewed by 483
Interests: tumor cell metabolism; intelligent intracerebral implants; drug repurposing
Special Issues, Collections and Topics in MDPI journals
Malignant brain tumors constitute a major therapeutic challenge which is in part due to the heterogenous nature of the diseases and the very special microenvironment within the brain. As a consequence, first- and second-line therapies widely fail to provide satisfactory clinical outcomes in these patients urging the search for more efficient therapies.
This Special Issue on “Novel Therapeutic Strategies for the Treatment of Brain Tumors” aims to provide a summary of novel developments for the treatment of adult and pediatric brain tumors. Emphasis will be given to novel mechanisms of tumor pathogenesis, immunologic approaches and therapeutics that target the tumor cell metabolism.
In this Issue, original research articles as well as mini and full reviews, including perspectives in the field on the current understanding of the pathogenesis and emerging therapies for brain tumors in children and adults are going to be presented. Manuscripts from both, basic and clinical researchers are welcome.
Dr. Georg Karpel-Massler
Dr. Mike-Andrew Westhoff
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- brain tumor
- tumor immunology
- tumor cell metabolism